United States
Choose your country or region:
France
Germany
Italy
Japan
United Kingdom
About
Leadership
Board of Directors
Company History
Corporate Impact and Community Relations
Health Equity
Our Collaborations
Contact Us
Newsroom
News & Stories
Press Releases
Multimedia
Our Tests
Cologuard®
OncoExTra™
Oncoguard® Liver
Oncotype DX®
Oncotype DX Breast DCIS Score®
Oncotype DX Breast Recurrence Score®
Oncotype DX Colon Recurrence Score®
Riskguard™
Provider
Patient
Pipeline & Data
Breast Radiation Score
Next Generation Cologuard
Colorectal Cancer Blood
LBgard® Blood Tubes
Molecular Residual Disease
Cancerguard™
Our Expertise
Cancerguard™ Science
Multi-Cancer Early Detection Thought Leadership
Clinical Studies
Research
Publications & Abstracts
Exact Academy
Investor Relations
Press Releases
Events & Presentations
Environmental, Social, and Governance (ESG)
Stock Information
Financial Information
Email Alerts
Contact Us
Join Our Team
×
DIGITAL NEWSROOM
Posts in:
Exact Sciences News
August 28, 2014
Cologuard® in the News: Week Two
August 25, 2014
Exact Sciences Announces Mayo Clinic as First Healthcare System to Offer Cologuard®
August 21, 2014
Cologuard in the News: Week One
August 12, 2014
FDA Approves Exact Sciences’ Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test
July 10, 2014
Exact Sciences CEO Kevin Conroy Presents on Entrepreneurship in the Midwest
October 29, 2013
Exact Sciences Reports On Q3 Earnings
September 13, 2013
Leadership Lessons from Exact Sciences' CEO Kevin Conroy
April 16, 2013
The DeeP-C Clinical Trial: A Physician's Perspective
1
2
3
4
5
6
7
8
9